NextFin

US Stock Pre-Market Report - September 23, 2026

Summarized by NextFin AI
  • U.S. equity-index futures traded slightly lower, with Nasdaq 100 futures down 0.23%, S&P 500 futures down 0.07%, and Dow Jones futures down 0.18%, as sentiment tied to oil volatility and diplomacy.
  • European equities were mixed, with UK FTSE 100 up 0.17% supported by banks, while Germany DAX fell 0.75% and France CAC 40 dropped 0.25% amid rate and oil concerns.
  • Commodities and FX were mixed, with WTI crude at $90.68, Brent at $100.26, gold futures down 0.70% to $4,345.55, silver down 1.44%, and the U.S. Dollar Index up 0.28%.
  • U.S. stock focus highlighted earnings and catalysts, including General Mills beating sales estimates, IonQ surging 11.8% on quantum milestone, TriSalus jumping 15.6% on FDA clearance, and Rivian recalling 98,828 vehicles.

NextFin News -

1) Pre-Market Performance

U.S. equity-index futures traded slightly lower ahead of the open, with the pullback concentrated in technology futures. Broader market sentiment remained tied to oil-price volatility, Middle East diplomacy and the upcoming U.S.-China summit.

  • Nasdaq 100 futures: 30,957.50, down 71.00 points, or 0.23%.
  • S&P 500 futures: 7,826.50, down 5.25 points, or 0.07%.
  • Dow Jones futures: 52,186.00, down 93.00 points, or 0.18%.

European equities were mixed in midday trading. The UK market held modest gains while continental benchmarks were softer, as investors weighed stronger regional activity data against renewed rate and oil-price concerns.

  • UK FTSE 100: 10,726.56, up about 18.2 points, or 0.17%; banks helped support the index while oil prices stayed near recent lows. FTSE 100 update
  • Germany DAX: 25,386.19, down about 191.8 points, or 0.75%. DAX quote
  • France CAC 40: 8,134.38, down about 20.4 points, or 0.25%. CAC 40 quote
  • Euro Stoxx 50: 6,292.03, down about 32.9 points, or 0.52%. Euro Stoxx 50 quote

Commodities and foreign exchange were mixed. WTI crude traded at $90.68, up $0.16, or 0.18%; Brent crude was at $100.26, up $1.01, or 1.02%; gold futures were at $4,345.55, down $30.85, or 0.70%; silver futures fell 1.44% to $65.57; and the U.S. Dollar Index rose 0.28% to 100.602. Market snapshot

2) Hot News

  • Wall Street futures muted as diplomacy stays in focus

    U.S. stock-index futures traded narrowly lower as investors monitored negotiations aimed at ending the Middle East conflict and looked ahead to the U.S.-China summit. The agenda is expected to include trade-truce extension issues, AI regulation and Taiwan-related tensions.

  • Oil market stabilizes after Saudi pipeline restart

    Crude prices remained volatile but below the most stressed levels seen earlier in the month after reports that Saudi Arabia restarted operations at its East-West Pipeline and may have resumed exports from Yanbu. Energy remains a key swing factor for equity risk appetite, inflation expectations and Treasury yields.

  • European markets digest stronger activity data

    European shares initially edged higher after euro-zone business activity accelerated unexpectedly, but gains were uneven across major national indexes. Banks and technology shares drew support, while some regional benchmarks later turned lower.

  • AI enthusiasm keeps technology leadership intact

    The Nasdaq Composite closed at a record high on Tuesday, supported by Micron Technology and other AI-linked stocks. Investors continued to reward companies exposed to AI infrastructure and monetization, even as parts of financials, travel and consumer-intermediary businesses remained pressured by disruption concerns.

3) U.S. Stock Focus

  • General Mills — First-quarter sales beat estimates

    General Mills reported quarterly sales of $4.39 billion, above the $4.35 billion analyst consensus, helped by improved demand for pantry staples and breakfast cereals. A separate earnings update showed EPS of $0.75, $0.03 above expectations, with the stock indicated slightly higher pre-market.

  • Meta Platforms — Muse AI agent remains a key market catalyst

    Meta is testing a human-concierge layer for phone calls placed through its Muse AI assistant, according to internal posts reported by Reuters. The development comes as Meta Connect begins today, with investors watching whether Muse can evolve from a viral app into a broader agent-commerce platform.

  • Micron Technology — Shares pause after sharp AI-driven rally

    Micron slipped 0.3% in pre-open trading to about $1,092.99 as investors took profits after a four-session rally of roughly 14% in September. The stock remains tied to AI memory-demand expectations ahead of its fiscal fourth-quarter 2026 earnings release scheduled for September 30.

  • IonQ — Quantum-computing milestone lifts shares

    IonQ surged 11.8% in pre-open trading after unveiling what it described as the industry's first end-to-end real-time quantum error-correction decoder operating on a single standard commercial CPU. The company also announced a multi-year partnership with South Korea's SDT that includes supplying a Superion 256 quantum computer.

  • TriSalus Life Sciences — FDA clearance drives pre-market rally

    TriSalus Life Sciences jumped 15.6% in pre-open trading after disclosing that the FDA granted 510(k) clearance for TriNav Advance. The device expands the company's Pressure-Enabled Drug Delivery portfolio for liver embolization procedures and is designed to reach smaller distal vessels through a compatible microcatheter.

  • Rivian Automotive — Nearly 99,000 vehicles recalled

    Rivian is recalling 98,828 vehicles in the U.S. due to a rearview-camera display issue that could obstruct the driver's rear view, according to the NHTSA. The recall affects certain R1S, R1T and R2 models, and Rivian is addressing the issue through a free over-the-air software update.

  • Grab Holdings — Executives buy shares after Atome-driven selloff

    Grab executives bought more than $30 million of company shares after the stock fell to a more than three-year low following its plan to acquire Atome Financial. CEO Anthony Tan purchased $30 million of stock, while President Alex Hungate bought about $867,000, and the shares closed 8.9% higher on Tuesday.

  • GRAIL — FDA advisory panel reviews Galleri test

    GRAIL faces a major regulatory catalyst today as the FDA's Molecular and Clinical Genetics Panel reviews the premarket approval application for Galleri, its multi-cancer early-detection blood test. The FDA meeting will include discussion, recommendations and a vote on the application for use in adults aged 50 or older.

Explore more exclusive insights at nextfin.ai.

Insights

What drives US futures lower today?

How does oil affect market sentiment?

What is the US-China summit agenda?

Why did Nasdaq hit record high?

How does AI fuel tech leadership?

What is Meta Muse AI agent?

Why did Micron shares pause rally?

What is IonQ quantum breakthrough?

Why did TriSalus stock surge today?

Why did Rivian recall vehicles today?

Why did Grab executives buy shares?

What is GRAIL FDA panel review?

How did Saudi pipeline restart oil?

Why are European markets mixed today?

Why did gold futures prices drop?

How does AI regulation affect stocks?

What is General Mills sales beat?

Why did Dollar Index rise today?

What risks face Middle East talks?

How does IonQ quantum correction work?

Search
NextFinNextFin
NextFin.Al
No Noise, only Signal.
Open App